Claritas Pharmaceuticals Inc CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

GREY:CLAZF - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by Jmk2454on Sep 06, 2019 8:26am

100 Views

Post# 30101414

RE:RE:RE:RE:RE:RE:RE:RE:RE:PHASE 3

MyKnight wrote: Funny i spoke to him on the 28 july for a few hours... first time i ve met him face to face...
He gave me the impression of being in control, definitivelly knowledgable and really calm.
You can tell that he has a strong knowledge of the product, and that he knows that the good time is coming......

We talk about shorting and we both agreed that this was a pain, and he also agreed with our vote against the split so the shorter wouldn t take advantage anymore...

But what made me apprciated his company was is passion for kaly, we re in good hands with robert farrell especially now that is bringing is money on kaly, this doesn t lie....

RE:RE:RE:RE:RE:RE:RE:PHASE 3

Just posting pros and cons. Pros patents and trials. You heard all the cons. Spoke with him July 9, for 23 minutes. Doing all be can but not easy. Obviously frustrated

Read more at https://stockhouse.com/companies/bullboard?symbol=v.kly&postid=30100852#VL0z5MM9HoZt4qMA.99

MyKnight - thank you for taking the time to attend that meeting and sharing information with us. I can’t imagine why anybody that has so many questions about Kalytera wouldn’t have made the time to go to that meeting also. The FACTS are they could have asked all of the questions they pose in a face to face just as you did. Rather they come on this board and make ridiculous accusations against real shareholders. Apparently that’s how rookies do it.

Thanks to everybody on here that posts valid information. I often read Stockhouse for the humor provided by a certain basher (with multiple accounts) until I get fed up, report and ignore.

Facebook has a great group for Kalytera investors. There you need to have actual FACTS or “regular/real” thoughts to participate in discussions. It has an excellent administrator (not me) who has REAL knowledge of Kalytera and follows it closely.

Looking forward to news soon - GLTA! jmk

Bullboard Posts

Elon Musk sued by SEC over Twitter stock purchases